Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process

被引：2

作者：

Leung, Sheldon S. ^{[1
]}

Usansky, Joel ^{[2
]}

Lynde, Robert ^{[3
]}

Thway, Theingi ^{[4
]}

Hendricks, Robert ^{[5
]}

Rusnak, David ^{[6
]}

机构：

[1] Pfizer Inc, Andover, MA 01810 USA

[2] Thermo Fisher Sci, Philadelphia, PA 19102 USA

[3] Hitachi Solut Amer Ltd, San Francisco, CA 94080 USA

[4] Amgen Inc, Thousand Oaks, CA 93012 USA

[5] Genentech Inc, San Francisco, CA 94080 USA

[6] BioAgilytix Labs Inc, Durham, NC 27713 USA

来源：

AAPS JOURNAL | 2012年 / 14卷 / 01期

关键词：

21 CFR Part 11; automated data interchange; common data standard; ligand-binding assays; metadata; STANDARDS;

D O I：

10.1208/s12248-011-9319-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：105 / 112

页数：8

共 3 条

[1] The proteomics standards initiative
Orchard, S
Hermjakob, H
Apweiler, R
[J]. PROTEOMICS, 2003, 3 (07) : 1374 - 1376
[2] Data standards for flow cytometry
Spidlen, Josef
Gentleman, Robert C.
Haaland, Perry D.
Langille, Morgan
Le Meur, Nolwenn
Ochs, Michael F.
Schmitt, Charles
Smith, Clayton A.
Treister, Adam S.
Brinkman, Ryan R.
[J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2006, 10 (02) : 209 - 214
[3] Universal Serial Bus Implementers Forum Inc, 2011, UN SER BUS 3 0 SPEC